Childhood Cancer

You are here

Home » Grants » All grants tagged with "Leukemia"

All grants tagged with "Leukemia"

Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML
Norihiro Watanabe, PhD
Baylor College of Medicine
Innovation Grants, Awarded 2024
RAF Dimer Inhibitor Treatment in Pediatric Acute Myeloid Leukemia
Kevin Shannon, MD
The Regents of the University of California San Francisco
Innovation Grants, Awarded 2024
Unraveling the Mechanisms of Inherited Predisposition to Childhood Leukemia
Vijay Sankaran, MD/PhD
Boston Children’s Hospital
Innovation Grants, Awarded 2024
In vivo transdermal generation of CD33 CAR T-cells towards acute myeloid leukemia
Ruby Sims, PhD
University of California, Los Angeles
Young Investigator Grants, Awarded 2024
Expanding roles of DNA repair protein RAD51 in transcription
Emily Alchaer
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2024
Cardiovascular comorbidities and cardiotoxicity as mechanisms for disparities in treatment outcomes for pediatric Acute Myeloid Leukemia
Emma Gombos
University of Pennsylvania
POST Program Grants, Awarded 2024
DYRK1A inhibition sensitizes SMARCA4 mutated ALL cells to chemotherapy drugs
Ashley Paik
Loma Linda University
POST Program Grants, Awarded 2024
Acute myeloid leukemia; bloodstream infections and supportive care
Caleb Unterlack
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2024
Analyzing the effect of the SIX1/EYA2 protein complex on leukemogenesis
Travis Reese
Emory University
POST Program Grants, Awarded 2024
Data driven response criteria in pediatric acute myeloid leukemia
Annie Aspesi
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2024

Pages

All childhood cancer types

Featured Hero

Arianna Hines

Arianna is a firecracker. She is loving, empathetic, and bold. At a mere 13 months old, Arianna was diagnosed with neuroblastoma and began intensive treatment with some life-threatening complications. Today she is NED and her family raises money for ALSF.
Read more »